Titlebook: Handbook of Biologics for Rheumatological Disorders; Neeraj Jain,Lalit Duggal Book 2022 The Editor(s) (if applicable) and The Author(s), u

Herbaceous

書目名稱Handbook of Biologics for Rheumatological Disorders影響因子(影響力)




書目名稱Handbook of Biologics for Rheumatological Disorders影響因子(影響力)學科排名




書目名稱Handbook of Biologics for Rheumatological Disorders網(wǎng)絡公開度




書目名稱Handbook of Biologics for Rheumatological Disorders網(wǎng)絡公開度學科排名




書目名稱Handbook of Biologics for Rheumatological Disorders被引頻次




書目名稱Handbook of Biologics for Rheumatological Disorders被引頻次學科排名




書目名稱Handbook of Biologics for Rheumatological Disorders年度引用




書目名稱Handbook of Biologics for Rheumatological Disorders年度引用學科排名




書目名稱Handbook of Biologics for Rheumatological Disorders讀者反饋




書目名稱Handbook of Biologics for Rheumatological Disorders讀者反饋學科排名

chance

Biologics in Rheumatoid Arthritis,ombination with hydroxychloroquine (200?mg/day), oral methotrexate (15?mg/week) and leflunomide (10?mg/day). Her physician hikes her disease modifying anti rheumatic drug (DMARD) doses to hydroxychloroquine (400?mg/day), subcutaneous methotrexate (25?mg/week) and leflunomide (20?mg/day) and adds low

Flu表流動

Biologics in Spondyloarthritis,vent. They are the single most effective treatment option by a distance for axial SpA (axSpA), where the science of rheumatology had found itself limited until a couple of decades back. Apart from their numero uno position in the management of Ankylosing Spondylitis (AS), they are also very effectiv

Trypsin

Biologics in Psoriatic Arthritis, enthesitis, dactylitis, skin and nail disease [1, 2]. Treatment of PsA has witnessed a sea change over the past two decades. Extra-articular manifestations including uveitis and inflammatory bowel disease, and comorbidities like obesity, metabolic disease and depression play critical roles in treat

頑固

Biologics in Gout,t. For the vast majority of patients, such therapy is sufficient to “cure” gout. Pegloticase, a biologic urate-lowering drug is in consideration when conventional urate-lowering treatments (ULTs) are ineffective due to inefficacy, intolerance, or contraindications. Similarly, low-dose prednisolone,

MUTED

Biologics in Systemic Lupus Erythematosus (SLE),e is characterized by periods of flare and remission, leading to accrual of damage in multiple organ systems, which is contributed by ongoing disease activity and treatment-related toxicities. More effective but less toxic therapies are unmet needs for the management of SLE. A number of novel agents

DEVIL

Incompetent

北極熊

Biologics in Idiopathic Inflammatory Myopathies,Treatable subtype of IIM include (juvenile) dermatomyositis ((j)DM), antisynthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM) and overlap/non-specific myositis [OM/NSM, formerly called polymyositis (PM)]. Treatment of Idiopathic inflammatory myositis (IIMs), is not only long and of

使增至最大